About us Contact Terms of Use Data Sources Publications FAQ
DCLK2 logo

DCLK2

Serine/threonine-protein kinase DCLK2

Expression

StudyTumor samplesMaxQ3Q2Q1MinNormal samplesMaxQ3Q2Q1MinLog2 (T vs N)
Adrenocortical (ACC) 77 2.09 1.60 1.45 1.24 0.46 126 1.64 1.48 1.41 1.35 -0.09 0.05
Bladder (BLCA) 406 2.04 1.20 0.95 0.71 -0.08 9 1.75 1.62 1.43 1.27 1.16 -0.49
Breast (BRCA) 1067 1.94 1.26 1.12 0.96 0.17 178 1.57 1.41 1.32 1.22 0.98 -0.20
Cervical (CESC) 297 1.77 0.93 0.72 0.54 0.04 10 1.67 1.60 1.44 1.37 0.83 -0.72
Cholangiocarcinoma (CHOL) 36 1.50 1.23 1.08 0.94 0.58 0
Colon (COAD) 443 1.66 1.02 0.82 0.66 -0.02 166 2.02 1.63 1.39 1.15 -0.09 -0.57
B-cell lymphoma (DLBC) 42 1.76 0.75 0.61 0.47 -0.01 337 1.04 0.37 0.19 -0.58 -0.00 0.43
Esophageal (ESCA) 142 1.45 0.94 0.77 0.57 0.17 271 1.86 1.08 0.92 0.83 -0.09 -0.14
Glioblastoma (GBM) 160 2.73 2.44 2.33 2.20 1.23 214 2.31 1.88 1.81 1.75 -0.09 0.52
Head and neck (HNSC) 432 1.54 0.87 0.71 0.55 -0.05 55 1.53 1.06 0.93 0.84 0.65 -0.23